已收盘 11-13 16:00:00 美东时间
+0.380
+7.17%
今日重点评级关注:摩根大通:维持CytomX Therapeutics"超配"评级,目标价从11美元升至12美元;康托·菲茨杰拉德:维持Exodus Movement"超配"评级,目标价从15美元升至16美元
11-13 11:50
Morgan Stanley analyst Angel Castillo maintains ITG (NASDAQ:ITG) with a Overweight and lowers the price target from $18 to $9.
11-12 19:28
There’s a lot to be optimistic about in the NA sector as 2 analysts just weighe...
11-11 23:10
ITG (NASDAQ:ITG) raises FY2026 sales outlook from $1.556 billion to $1.578 billion vs $1.560 billion estimate.
11-11 21:26
ITG (NASDAQ:ITG) sees Q4 sales of $378.000 million vs $378.260 million analyst estimate.
11-11 21:26
ITG (NASDAQ:ITG) reported quarterly sales of $461.528 million which beat the analyst consensus estimate of $446.544 million by 3.36 percent.
11-11 14:16
今日重点评级关注:富国银行:维持Helus Pharma"超配"评级,目标价从16美元升至22美元;美银证券:维持SpaceX"买入"评级,目标价从235美元升至275美元
10-23 12:30
Stifel analyst Brian Brophy maintains ITG (NASDAQ:ITG) with a Buy and lowers the price target from $16 to $9.
10-22 20:51
今日重点评级关注:Jones Trading:维持Contineum Therapeutics"买入"评级,目标价从24美元升至30美元;StoneX:维持Forum Markets"投机性买入"评级,目标价从9美元升至12美元
10-16 12:30
Keybanc analyst Sangita Jain maintains ITG (NASDAQ:ITG) with a Overweight and lowers the price target from $17 to $13.
10-15 20:45